Autolus Therapeutics Plc logo

Autolus Therapeutics Plc Share Price Today

(NASDAQ: AUTL)

Autolus Therapeutics Plc share price is $1.79 & ₹155.93 as on 26 Feb 2025, 2.30 'hrs' IST

$1.79

-0.09

(-4.79%)

Market is closed - opens 8 PM, 26 Feb 2025

View live Autolus Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Autolus Therapeutics Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Autolus Therapeutics Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Autolus Therapeutics Plc share price movements

  • Today's Low: $1.79
    Today's High: $1.92

    Day's Volatility :6.77%

  • 52 Weeks Low: $1.79
    52 Weeks High: $6.63

    52 Weeks Volatility :72.98%

Autolus Therapeutics Plc (AUTL) Returns

PeriodAutolus Therapeutics PlcSector (Health Care)Index (Russel 2000)
3 Months
-42.51%
1.5%
0.0%
6 Months
-52.04%
-5.0%
0.0%
1 Year
-69.38%
-0.2%
0.0%
3 Years
-49.73%
12.7%
-13.3%

Autolus Therapeutics Plc (AUTL) Key Statistics

in dollars & INR

Previous Close
$1.88
Open
$1.9
Today's High
$1.92
Today's Low
$1.79
Market Capitalization
$500.3M
Today's Volume
$1.4M
52 Week High
$6.625
52 Week Low
$1.79
Revenue TTM
$10.1M
EBITDA
$-210.8M
Earnings Per Share (EPS)
$-1.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-82.2%

How to invest in Autolus Therapeutics Plc Stock (AUTL) from India?

It is very easy for Indian residents to invest directly in Autolus Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Autolus Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Autolus Therapeutics Plc or AUTL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Autolus Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Autolus Therapeutics Plc shares which would translate to 0.487 fractional shares of Autolus Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Autolus Therapeutics Plc, in just a few clicks!

Returns in Autolus Therapeutics Plc (AUTL) for Indian investors in Rupees

The Autolus Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Autolus Therapeutics Plc investment value today

Current value as on today

₹34,244

Returns

₹65,756

(-65.76%)

Returns from Autolus Therapeutics Plc Stock

₹70,847 (-70.85%)

Dollar Returns

₹5,091 (+5.09%)

Indian investors sentiment towards Autolus Therapeutics Plc (AUTL)

-36%

Period: Jan 26, 2025 to Feb 25, 2025. Change in 30 Days versus previous period

Search interest for Autolus Therapeutics Plc Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Autolus Therapeutics Plc

  • Wellington Management Company LLP

    9.52%

  • Blackstone Inc

    7.70%

  • Syncona Portfolio Ltd.

    6.25%

  • FMR Inc

    5.87%

  • Deep Track Capital, LP

    5.34%

  • venBio Select Advisor LLC

    3.72%

Analyst Recommendation on Autolus Therapeutics Plc

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Autolus Therapeutics Plc(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Autolus Therapeutics Plc Stock (AUTL)

What analysts predicted

Upside of 483.8%

Target:

$10.45

Current:

$1.79

Insights on Autolus Therapeutics Plc Stock (Ticker Symbol: AUTL)

  • Price Movement

    In the last 3 months, AUTL stock has moved down by -36.9%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 406.0K → 10.09M (in $), with an average increase of 79.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -52.69M → -82.09M (in $), with an average decrease of 25.7% per quarter
  • AUTL vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 66.7% return, outperforming this stock by 135.9%
  • AUTL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.7% return, outperforming this stock by 72.6%
  • Price to Sales

    ForAUTL every $1 of sales, investors are willing to pay $43.7, whereas for Beone Medicines Ltd, the investors are paying $1.1 for every $1 of sales.

Autolus Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Autolus Therapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Autolus Therapeutics Plc (AUTL) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Autolus Therapeutics Plc logo
-16.81%
-52.04%
-69.38%
-49.73%
-77.02%
Regeneron Pharmaceuticals, Inc. logo
4.17%
-40.53%
-28.2%
15.35%
60.44%
Beone Medicines Ltd logo
14.76%
30.45%
43.85%
22.79%
63.24%
Vertex Pharmaceuticals Incorporated logo
8.51%
-1.65%
11.77%
109.39%
114.99%
Alnylam Pharmaceuticals, Inc. logo
-10.04%
-11.31%
56.57%
57.71%
111.58%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Autolus Therapeutics Plc logo
NA
NA
NA
-0.91
-0.82
-0.22
NA
1.79
Regeneron Pharmaceuticals, Inc. logo
18.28
18.28
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
-5.69
-0.23
-0.1
NA
226.72
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.11
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.59
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Autolus Therapeutics Plc logo
Buy
$500.3M
-77.02%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$76.6B
60.44%
18.28
31.07%
Beone Medicines Ltd logo
NA
$29.9B
63.24%
NA
-25.5%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.3B
114.99%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$32.4B
111.58%
NA
-12.37%

About Autolus Therapeutics Plc

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. Autolus Therapeutics plc was incorporated in 2014 and is headquartered in London, the United Kingdom.
Organization
Autolus Therapeutics Plc
Employees
463
CEO
Dr. Christian Martin Itin Ph.D.
Industry
Health Technology

Management People of Autolus Therapeutics Plc

NameTitle
Dr. Christian Martin Itin Ph.D.
CEO & Director
Dr. Martin Pule M.D., MBBS
Founder, Senior VP & Chief Scientific Officer
Mr. Robert F. Dolski
Senior VP & CFO
Mr. Christopher Vann
Senior VP & COO
Mr. David Brochu
Senior VP & Chief Technical Officer
Mr. Alexander Swan
Senior VP & Chief Human Resources Officer
Mr. Brent Rice
Senior VP, Chief Commercial Officer & Site Head of US
Ms. Olivia Manser
Director of Investor Relations
Mr. Alex Driggs
Senior VP of Legal Affairs & General Counsel and Secretary
Dr. Chris Williams
Chief Business Officer

Important FAQs about investing in AUTL Stock from India :

What is Autolus Therapeutics Plc share price today?

Autolus Therapeutics Plc share price today stands at $1.79, Open: $1.90 ; Previous Close: $1.88 ; High: $1.92 ; Low: $1.79 ; 52 Week High: $6.63 ; 52 Week Low: $1.79.

The stock opens at $1.90, after a previous close of $1.88. The stock reached a daily high of $1.92 and a low of $1.79, with a 52-week high of $6.63 and a 52-week low of $1.79.

Can Indians buy Autolus Therapeutics Plc shares?

Yes, Indians can invest in the Autolus Therapeutics Plc (AUTL) from India.

With INDmoney, you can buy Autolus Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Autolus Therapeutics Plc at zero transaction cost.

How can I buy Autolus Therapeutics Plc shares from India?

It is very easy to buy Autolus Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Autolus Therapeutics Plc (AUTL) be purchased?

Yes, you can buy fractional shares of Autolus Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Autolus Therapeutics Plc stocks?

To start investing in Autolus Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Autolus Therapeutics Plc Stock (AUTL)?

Today’s highest price of Autolus Therapeutics Plc (AUTL) is $1.92.

Today’s lowest price of Autolus Therapeutics Plc (AUTL) is $1.79.

What is today's market capitalisation of Autolus Therapeutics Plc?

Today's market capitalisation of Autolus Therapeutics Plc AUTL is 500.3M

What is the 52 Week High and Low Range of Autolus Therapeutics Plc Stock (AUTL)?

  • 52 Week High

    $6.63

  • 52 Week Low

    $1.79

What are the historical returns of Autolus Therapeutics Plc (AUTL)?

  • 1 Month Returns

    -16.81%

  • 3 Months Returns

    -52.04%

  • 1 Year Returns

    -69.38%

  • 5 Years Returns

    -77.02%

Who is the Chief Executive Officer (CEO) of Autolus Therapeutics Plc ?

Dr. Christian Martin Itin Ph.D. is the current Chief Executive Officer (CEO) of Autolus Therapeutics Plc.